LLY News and Press, Eli Lilly and Company From 01/31/24

2024-01-31 12:32:57 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Novo Nordisk stock hits all-time high as Wegov...

2024-01-30 22:19:09 ET Summary Seeking Alpha Quant rates MTUM as a buy with a high rating. MTUM has strong momentum and is outperforming the broad market during the current rally. The top holdings of MTUM are highly profitable and expected to continue performing well in the lo...

2024-01-30 16:23:19 ET Summary Anti-amyloid drugs likely have little effect on non-APOE4 carriers. Anti-amyloid antibody drugs may have an effect on APOE4 carriers, but with serious and potentially fatal side effects. Safety issues, including potential adverse brain events, ma...

2024-01-30 08:59:38 ET Health Canada has approved Eli Lilly's ( NYSE: LLY ) oral drug, Olumiant (baricitinib), for the treatment of severe alopecia areata, a common autoimmune hair loss disorder.... Read the full article on Seeking Alpha For further details see: ...

2024-01-29 15:13:38 ET More on Karuna Therapeutics Karuna Therapeutics: Rewiring The Schizophrenia Paradigm - A Novel Leap Beyond Dopamine Karuna Therapeutics, Inc. (KRTX) Q3 2023 Earnings Conference Call Transcript M&A activity expected to pick up in 2024, banke...

2024-01-29 11:25:59 ET Eli Lilly & Co (NYSE: LLY) is in the green this morning following a report that it’s in talks with Germany to have its weight-loss drug be included in the country’s public health coverage. Lilly is ‘optimistic’ on discussions wi...

2024-01-29 10:20:11 ET More on Eli Lilly Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly: The Buzz Is Not Over Big Pharma earnings season in spotlight amid positive sentiment Eli Lilly's Mounjaro dose ava...

2024-01-29 06:26:00 ET Microsoft , Apple , Nvidia , Amazon , Alphabet , Meta Platforms , and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the " Magnificent Seven ," -- have taken the market by storm for an incredible outperformanc...

2024-01-29 03:29:00 ET The stock market delivered a strong performance over the trailing-12-month period. That makes what Eli Lilly (NYSE: LLY) and Booking Holdings (NASDAQ: BKNG) have accomplished over this period even more impressive, as both companies easily crushed the ...

2024-01-28 12:00:53 ET More on Amgen, Vertex Pharma, etc. Biotech And Pharma Diversification Pays Off Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks Vertex And Crispr: Second Casgevy Approval Pushes Revenue Potential Into Multi-Billion Dollar...